These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35561716)

  • 1. Misunderstanding poor adherence to COVID-19 vaccination in Africa - Authors' reply.
    Mutombo PN; Fallah MP; Munodawafa D; Kabel A; Houeto D; Goronga T; Mweemba O; Balance G; Onya H; Kamba RS; Chipimo M; Kayembe JN; Akanmori B
    Lancet Glob Health; 2022 Jun; 10(6):e795. PubMed ID: 35561716
    [No Abstract]   [Full Text] [Related]  

  • 2. Misunderstanding poor adherence to COVID-19 vaccination in Africa.
    Seytre B
    Lancet Glob Health; 2022 Jun; 10(6):e794. PubMed ID: 35561715
    [No Abstract]   [Full Text] [Related]  

  • 3. Why SARS-CoV-2 vaccination still matters in Africa.
    Taylor-Robinson SD; Morgan MY; Spearman CW; Suliman AAA; Corrah T; Oleribe OO; Taylor-Robinson AW
    QJM; 2022 Mar; 115(3):191-192. PubMed ID: 35080615
    [No Abstract]   [Full Text] [Related]  

  • 4. The long road ahead for COVID-19 vaccination in Africa.
    Jerving S
    Lancet; 2021 Sep; 398(10303):827-828. PubMed ID: 34481563
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Buchbinder SP; McElrath MJ; Dieffenbach C; Corey L
    Lancet; 2022 Apr; 399(10333):e36. PubMed ID: 35397867
    [No Abstract]   [Full Text] [Related]  

  • 6. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.
    Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H
    Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quest for more COVID-19 vaccinations in Africa.
    Makoni M
    Lancet Respir Med; 2022 Jul; 10(7):e70-e71. PubMed ID: 35623372
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply.
    Alexander JL; Kennedy NA; Lees CW; Ahmad T; Powell N;
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):523-524. PubMed ID: 34119033
    [No Abstract]   [Full Text] [Related]  

  • 9. Authors' Reply to Sprengholz and Betsch: "Willingness to Pay for a COVID-19 Vaccine".
    García LY; Cerda AA
    Appl Health Econ Health Policy; 2021 Jul; 19(4):623-624. PubMed ID: 33973149
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse event reporting and Bell's palsy risk after COVID-19 vaccination - Authors' reply.
    Wong ICK; Wan EYF; Chui CSL; Li X; Chan EWY
    Lancet Infect Dis; 2021 Nov; 21(11):1492-1493. PubMed ID: 34717806
    [No Abstract]   [Full Text] [Related]  

  • 11. The Future of SARS-CoV-2 Vaccination. Reply.
    Monto AS
    N Engl J Med; 2022 Mar; 386(9):899-900. PubMed ID: 35235738
    [No Abstract]   [Full Text] [Related]  

  • 12. Feelings towards COVID-19 vaccination in Africa.
    Samarasekera U
    Lancet Infect Dis; 2021 Mar; 21(3):324. PubMed ID: 33639125
    [No Abstract]   [Full Text] [Related]  

  • 13. Applications of telemedicine in the supply and distribution of COVID-19 vaccines in Africa.
    Okereke M; Babatunde AO; Samuel ST; Ogunkola IO; Mogessie YG; Lucero-Prisno DE
    J Glob Health; 2021 Mar; 11():03039. PubMed ID: 33828830
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 vaccine trials must include helminth-infected cohorts.
    Egwang TG; Owalla TJ; Kemigisha M
    Nat Immunol; 2022 Feb; 23(2):148. PubMed ID: 35075281
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.
    Massinga Loembé M; Nkengasong JN
    Immunity; 2021 Jul; 54(7):1353-1362. PubMed ID: 34260880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against SARS-CoV-2 after Vaccination and Previous Infection. Reply.
    Hopkins S; Hall V; Klenerman P
    N Engl J Med; 2022 Jun; 386(26):2535. PubMed ID: 35704418
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 vaccine hesitancy in Africa: a call to action.
    Mutombo PN; Fallah MP; Munodawafa D; Kabel A; Houeto D; Goronga T; Mweemba O; Balance G; Onya H; Kamba RS; Chipimo M; Kayembe JN; Akanmori B
    Lancet Glob Health; 2022 Mar; 10(3):e320-e321. PubMed ID: 34942117
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection.
    Xu W; Su S; Jiang S
    Clin Transl Med; 2021 Feb; 11(2):e331. PubMed ID: 33634979
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply.
    Sawadogo NH; Sanou H; Greene JA; Duclos V
    Lancet; 2021 Nov; 398(10315):1963. PubMed ID: 34838174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.